These results suggest that ethnic‐specific variations in the TP53 pathway are more pronounced in colon cancer, and TP53 pathway alterations may contribute to ethnic disparities in CRC prognosis and outcomes. This evidence concerns the gene TP53 and malignant colon neoplasm.